Skip to main content

This document was published by the U.S. Department of Health and Human Services on March 19, 2019. The purpose of the guidance is to provide general recommendations on the development of antiretroviral drug products for the treatment of human immunodeficiency virus (HIV) infection in pediatric health care consumers . . .

Content Restricted

This article is reserved for members with an active Standard Membership. Please purchase a Standard Membership to view this resource.


Tagged As:

Login to access The OPEN MINDS Circle Library. Not a member? Create your free account now!

Close

Support Request

Need help now?

Call our toll-free phone number 877-350-6463